Overview The Bleeding With Antithrombotic Therapy Study 2 Status: Recruiting Trial end date: 2022-03-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the incidence and severity of bleeding complications in patients with cerebrovascular and cardiovascular diseases treated with oral antithrombotic therapy. Details Lead Sponsor: National Cerebral and Cardiovascular CenterCollaborator: Japan Agency for Medical Research and DevelopmentTreatments: Anticoagulants